Product Showcase

The HHS Intramural Research Programs have invented numerous technologies that were licensed to companies for commercial development and now are on the market. Products showcased on this site are utilized every day to detect, treat or prevent disease or assist researchers as they continue to explore ways to develop newer and more effective health care products and procedures.

The Showcase includes products that are now or have been on the market. Some are FDA-approved and many do not necessitate FDA approval. While there may be multiple inventors on any product, all of whom may not be from HHS, the primary purpose of this Showcase is to highlight the contributions of HHS. 

We hope you will find this Showcase illuminating about the role the HHS Intramural Research Programs have played in the effort to advance significantly our capacity to protect and improve health.

Bristol-Myers Squibb Company

Treatment of advanced HIV infection in adults or children older than 6 months

BioMerieux, Inc.

Screens for HTLV-I/II

Organon Teknika

Screens for HTLV-I/II

Isis Pharmaceuticals, Inc.

Inhibition of CMV eye infections

Invitrogen Corporation

Used for the detection of enzyme-drug interactions and CYP450 inhibition

Invitrogen Corporation

Enables fast measurements of interactions between drug candidates and cytochrome p450 enzymes.

Kite Pharma

Treatment of relapsed or refractory large B-cell lymphoma.

Protein Design Laboratory / Hoffman LaRoche

Prevention of acute kidney transplant rejection

Coulter Corporation

Treatment of patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Angiotech Pharmaceuticals / Cook Medical

Used to prevent restenosis after balloon angioplasty of peripheral arteries

Biogen

Treatment of HIV-1 infection.

Progeria Research Foundation, Elger BioPharmaceuticals

Treatment of Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies.